Investor Overview

Corporate Profile
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, that enables simple, low cost and highly sensitive genomic and protein testing on a single platform. Our proprietary nanoparticle technology simplifies the ability to perform molecular diagnostic tests, achieves ultra-sensitive protein detection at limits beyond current diagnostic technologies, provides the ability to multiplex, or run multiple tests at the same time on the same sample, and enables the development of a broad menu of test assays to be... More >>
Stock Quote
NSPH (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$3.11
Change (%) Stock is Up 0.09 (2.98%)
Volume30,223
Data as of 09/08/10 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock chart for: 03NA000000NSPH
PresentationsMore >>
DateTitle
08/24/10
Company Overview Adobe PDF
Recent NewsMore >>
08/24/10 - 4:01 p.m.
Nanosphere Acquires the Rights to Intellectual Properties
08/05/10 - 4:05 p.m.
Nanosphere Announces Second Quarter 2010 Results
07/22/10 - 4:34 p.m.
Nanosphere to Release Q2 2010 Earnings Results and Hold Investor Call Thursday, August 5
Upcoming EventsMore >>
DateTitle
09/12/10
through
09/15/10
NANOSPHERE INC at 2010 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
LocationBoston, MA
09/24/10
NANOSPHERE INC - Updates in Lab Medicine (MedCity)
LocationDallas, TX

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.